Funder
National Heart, Lung, and Blood Institute
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference20 articles.
1. Bayliss, M., McCausland, K. L., Guthrie, S. D., & White, M. K. (2017). The burden of amyloid light chain amyloidosis on health-related quality of life. Orphanet Journal of Rare Diseases, 12(1), 15. https://doi.org/10.1186/s13023-016-0564-2
2. Merlini, G. (2017). AL amyloidosis: from molecular mechanisms to targeted therapies. Hematology/The Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2017(1), 1–12.
3. Lousada, I., Comenzo, R. L., Landau, H., Guthrie, S., & Merlini, G. (2015). Light chain amyloidosis: Patient experience survey from the Amyloidosis Research Consortium. Advances in Therapy, 32(10), 920–928.
4. Muchtar, E., Gertz, M. A., Kumar, S. K., Lacy, M. Q., Dingli, D., Buadi, F. K., ... & Dispenzieri, A. (2017). Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death. Blood, 129(15), 2111–2119. https://doi.org/10.1182/blood-2016-11-751628
5. Kumar, S. K., Gertz, M. A., Lacy, M. Q., Dingli, D., Hayman, S. R., Buadi, F. K., et al. (2011). Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clinic Proceedings, 86(1), 12–18. https://doi.org/10.4065/mcp.2010.0480
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献